169 related articles for article (PubMed ID: 8165183)
1. Bile salt-fatty acid mixed micelles as nasal absorption promoters. III. Effects on nasal transport and enzymatic degradation of acyclovir prodrugs.
Shao Z; Mitra AK
Pharm Res; 1994 Feb; 11(2):243-50. PubMed ID: 8165183
[TBL] [Abstract][Full Text] [Related]
2. The physicochemical properties, plasma enzymatic hydrolysis, and nasal absorption of acyclovir and its 2'-ester prodrugs.
Shao Z; Park GB; Krishnamoorthy R; Mitra AK
Pharm Res; 1994 Feb; 11(2):237-42. PubMed ID: 8165182
[TBL] [Abstract][Full Text] [Related]
3. Nasal membrane and intracellular protein and enzyme release by bile salts and bile salt-fatty acid mixed micelles: correlation with facilitated drug transport.
Shao Z; Mitra AK
Pharm Res; 1992 Sep; 9(9):1184-9. PubMed ID: 1409402
[TBL] [Abstract][Full Text] [Related]
4. Acyclovir permeation enhancement across intestinal and nasal mucosae by bile salt-acylcarnitine mixed micelles.
Park GB; Shao Z; Mitra AK
Pharm Res; 1992 Oct; 9(10):1262-7. PubMed ID: 1448423
[TBL] [Abstract][Full Text] [Related]
5. Chemical stability, enzymatic hydrolysis, and nasal uptake of amino acid ester prodrugs of acyclovir.
Yang C; Gao H; Mitra AK
J Pharm Sci; 2001 May; 90(5):617-24. PubMed ID: 11288106
[TBL] [Abstract][Full Text] [Related]
6. Bile salt-fatty acid mixed micelles as nasal absorption promoters of peptides. I. Effects of ionic strength, adjuvant composition, and lipid structure on the nasal absorption of [D-Arg2]kyotorphin.
Tengamnuay P; Mitra AK
Pharm Res; 1990 Feb; 7(2):127-33. PubMed ID: 2308892
[TBL] [Abstract][Full Text] [Related]
7. The influence of absorption enhancers on nasal absorption of acyclovir.
Chavanpatil MD; Vavia PR
Eur J Pharm Biopharm; 2004 May; 57(3):483-7. PubMed ID: 15093597
[TBL] [Abstract][Full Text] [Related]
8. Bile salt-fatty acid mixed micelles as nasal absorption promoters of peptides. II. In vivo nasal absorption of insulin in rats and effects of mixed micelles on the morphological integrity of the nasal mucosa.
Tengamnuay P; Mitra AK
Pharm Res; 1990 Apr; 7(4):370-5. PubMed ID: 2194199
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of amino acid ester prodrugs of acyclovir after oral administration: interaction with the transporters on Caco-2 cells.
Katragadda S; Jain R; Kwatra D; Hariharan S; Mitra AK
Int J Pharm; 2008 Oct; 362(1-2):93-101. PubMed ID: 18638532
[TBL] [Abstract][Full Text] [Related]
10. Transport of acyclovir ester prodrugs through rabbit cornea and SIRC-rabbit corneal epithelial cell line.
Tak RV; Pal D; Gao H; Dey S; Mitra AK
J Pharm Sci; 2001 Oct; 90(10):1505-15. PubMed ID: 11745709
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of nasal absorption of drugs. III: Nasal absorption of leucine enkephalin.
Faraj JA; Hussain AA; Aramaki Y; Iseki K; Kagoshima M; Dittert LW
J Pharm Sci; 1990 Aug; 79(8):698-702. PubMed ID: 2231332
[TBL] [Abstract][Full Text] [Related]
12. 5'-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter.
Han H; de Vrueh RL; Rhie JK; Covitz KM; Smith PL; Lee CP; Oh DM; Sadée W; Amidon GL
Pharm Res; 1998 Aug; 15(8):1154-9. PubMed ID: 9706043
[TBL] [Abstract][Full Text] [Related]
13. Dissociation of insulin oligomers by bile salt micelles and its effect on alpha-chymotrypsin-mediated proteolytic degradation.
Li Y; Shao Z; Mitra AK
Pharm Res; 1992 Jul; 9(7):864-9. PubMed ID: 1437998
[TBL] [Abstract][Full Text] [Related]
14. Quantitative estimation of the effects of bile salt surfactant systems on insulin stability and permeability in the rat intestine using a mass balance model.
Lane ME; O'driscoll CM; Corrigan OI
J Pharm Pharmacol; 2005 Feb; 57(2):169-75. PubMed ID: 15720779
[TBL] [Abstract][Full Text] [Related]
15. In vivo evaluation of acyclovir prodrug penetration and metabolism through rat skin using a diffusion/bioconversion model.
Bando H; Sahashi M; Yamashita F; Takakura Y; Hashida M
Pharm Res; 1997 Jan; 14(1):56-62. PubMed ID: 9034221
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of the systemic and CNS specific delivery of L-dopa by the nasal administration of its water soluble prodrugs.
Kao HD; Traboulsi A; Itoh S; Dittert L; Hussain A
Pharm Res; 2000 Aug; 17(8):978-84. PubMed ID: 11028945
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, metabolism and cellular permeability of enzymatically stable dipeptide prodrugs of acyclovir.
Talluri RS; Samanta SK; Gaudana R; Mitra AK
Int J Pharm; 2008 Sep; 361(1-2):118-24. PubMed ID: 18573320
[TBL] [Abstract][Full Text] [Related]
18. Cellular uptake mechanism of amino acid ester prodrugs in Caco-2/hPEPT1 cells overexpressing a human peptide transporter.
Han HK; Oh DM; Amidon GL
Pharm Res; 1998 Sep; 15(9):1382-6. PubMed ID: 9755889
[TBL] [Abstract][Full Text] [Related]
19. Cyclodextrins as nasal absorption promoters of insulin: mechanistic evaluations.
Shao Z; Krishnamoorthy R; Mitra AK
Pharm Res; 1992 Sep; 9(9):1157-63. PubMed ID: 1409397
[TBL] [Abstract][Full Text] [Related]
20. Increased acyclovir oral bioavailability via a bile acid conjugate.
Tolle-Sander S; Lentz KA; Maeda DY; Coop A; Polli JE
Mol Pharm; 2004 Jan; 1(1):40-8. PubMed ID: 15832499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
